"Our company is committed to manufacturing quality vaccines at prices that make them one of the most cost-effective investments in global health. We are very proud to support immunisation needs of the world's poorest countries and supply life-saving vaccines to underprivileged children in the world," said Mahima Datla, managing director of Biological E after meeting Bill Gates.